Schultze and Clever Leaves Revise Deal Terms

Clever Leaves

Schultze and Clever Leaves announced today that they have amended their definitive merger agreement. Under the revised terms, the expected enterprise value has been reduced to $206 million from $255 million and the minimum cash condition for the SPAC has been reduced to $26 million from $60 million. The deal is expected to close by year’s end.

Clever is a pharmaceutical-grade multi-national cannabis operator.

If approved, Clever will trade on the NASDAQ under the symbol “CLVR”. Read more.

Total
0
Shares
Related Posts
B. Riley
Read More

B. Riley Principal 250 Prices $150M IPO

The SPAC said it intends "to focus on businesses that have a history of, or potential for, strong cash flow generation and growing revenue streams, and would benefit from access to public markets and the operational and strategic expertise of its management team and board of directors."